| Global Tuberculosis Control WH Organization | 16337* | 2007 |
| Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country C Dye, S Scheele, V Pathania, MC Raviglione Jama 282 (7), 677-686, 1999 | 4322 | 1999 |
| The growing burden of tuberculosis: global trends and interactions with the HIV epidemic EL Corbett, CJ Watt, N Walker, D Maher, BG Williams, MC Raviglione, ... Archives of internal medicine 163 (9), 1009-1021, 2003 | 3578 | 2003 |
| Disease control priorities in developing countries DT Jamison, JG Breman, AR Measham, G Alleyne, M Claeson, DB Evans, ... The World Bank, 2006 | 2439 | 2006 |
| Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model RM Granich, CF Gilks, C Dye, KM De Cock, BG Williams The Lancet 373 (9657), 48-57, 2009 | 2043 | 2009 |
| Estimates of world-wide distribution of child deaths from acute respiratory infections BG Williams, E Gouws, C Boschi-Pinto, J Bryce, C Dye The Lancet infectious diseases 2 (1), 25-32, 2002 | 981 | 2002 |
| Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness BB Trunz, PEM Fine, C Dye The Lancet 367 (9517), 1173-1180, 2006 | 970 | 2006 |
| Global trends in resistance to antituberculosis drugs MA Espinal, A Laszlo, L Simonsen, F Boulahbal, SJ Kim, A Reniero, ... New England Journal of Medicine 344 (17), 1294-1303, 2001 | 951 | 2001 |
| Global epidemiology of tuberculosis C Dye The Lancet 367 (9514), 938-940, 2006 | 941 | 2006 |
| Heterogeneities in the transmission of infectious agents: implications for the design of control programs MEJ Woolhouse, C Dye, JF Etard, T Smith, JD Charlwood, GP Garnett, ... Proceedings of the National Academy of Sciences 94 (1), 338-342, 1997 | 886 | 1997 |
| Drivers of tuberculosis epidemics: the role of risk factors and social determinants K Lönnroth, E Jaramillo, BG Williams, C Dye, M Raviglione Social science & medicine 68 (12), 2240-2246, 2009 | 879 | 2009 |
| Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries MA Espinal, SJ Kim, PG Suarez, KM Kam, AG Khomenko, GB Migliori, ... Jama 283 (19), 2537-2545, 2000 | 821 | 2000 |
| Global incidence of multidrug-resistant tuberculosis M Zignol, MS Hosseini, A Wright, CL Weezenbeek, P Nunn, CJ Watt, ... The Journal of infectious diseases 194 (4), 479-485, 2006 | 732 | 2006 |
| Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally C Dye, CJ Watt, DM Bleed, SM Hosseini, MC Raviglione Jama 293 (22), 2767-2775, 2005 | 669 | 2005 |
| The population dynamics and control of tuberculosis C Dye, BG Williams Science 328 (5980), 856-861, 2010 | 635 | 2010 |
| Prospects for worldwide tuberculosis control under the WHO DOTS strategy C Dye, GP Garnett, K Sleeman, BG Williams The Lancet 352 (9144), 1886-1891, 1998 | 606 | 1998 |
| Alcohol use as a risk factor for tuberculosis–a systematic review K Lönnroth, BG Williams, S Stadlin, E Jaramillo, C Dye BMC public health 8 (1), 289, 2008 | 505 | 2008 |
| Global tuberculosis control-epidemiology, strategy, financing. AQ Khan, A Wako, B Ayalew, M Tefera, Y Tadesse, BL Batzing, ... Journal of Medical Sciences 13 (5), 926-937, 2002 | 501 | 2002 |
| The potential impact of male circumcision on HIV in Sub-Saharan Africa BG Williams, JO Lloyd-Smith, E Gouws, C Hankins, WM Getz, J Hargrove, ... PLoS medicine 3 (7), e262, 2006 | 494 | 2006 |
| Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence CR Stevenson, NG Forouhi, G Roglic, BG Williams, JA Lauer, C Dye, ... BMC public health 7 (1), 234, 2007 | 484 | 2007 |
